240 related articles for article (PubMed ID: 32916131)
1. Oxidative Metabolism Drives Immortalization of Neural Stem Cells during Tumorigenesis.
Bonnay F; Veloso A; Steinmann V; Köcher T; Abdusselamoglu MD; Bajaj S; Rivelles E; Landskron L; Esterbauer H; Zinzen RP; Knoblich JA
Cell; 2020 Sep; 182(6):1490-1507.e19. PubMed ID: 32916131
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of oxidative metabolism leads to p53 genetic inactivation and transformation in neural stem cells.
Bartesaghi S; Graziano V; Galavotti S; Henriquez NV; Betts J; Saxena J; Minieri V; A D; Karlsson A; Martins LM; Capasso M; Nicotera P; Brandner S; De Laurenzi V; Salomoni P
Proc Natl Acad Sci U S A; 2015 Jan; 112(4):1059-64. PubMed ID: 25583481
[TBL] [Abstract][Full Text] [Related]
3. NANOG Metabolically Reprograms Tumor-Initiating Stem-like Cells through Tumorigenic Changes in Oxidative Phosphorylation and Fatty Acid Metabolism.
Chen CL; Uthaya Kumar DB; Punj V; Xu J; Sher L; Tahara SM; Hess S; Machida K
Cell Metab; 2016 Jan; 23(1):206-19. PubMed ID: 26724859
[TBL] [Abstract][Full Text] [Related]
4. Stem cells in brain tumor development.
Alcantara Llaguno SR; Chen Y; McKay RM; Parada LF
Curr Top Dev Biol; 2011; 94():15-44. PubMed ID: 21295683
[TBL] [Abstract][Full Text] [Related]
5. Neural stem cell temporal patterning and brain tumour growth rely on oxidative phosphorylation.
van den Ameele J; Brand AH
Elife; 2019 Sep; 8():. PubMed ID: 31513013
[TBL] [Abstract][Full Text] [Related]
6. YAP1 subgroup supratentorial ependymoma requires TEAD and nuclear factor I-mediated transcriptional programmes for tumorigenesis.
Pajtler KW; Wei Y; Okonechnikov K; Silva PBG; Vouri M; Zhang L; Brabetz S; Sieber L; Gulley M; Mauermann M; Wedig T; Mack N; Imamura Kawasawa Y; Sharma T; Zuckermann M; Andreiuolo F; Holland E; Maass K; Körkel-Qu H; Liu HK; Sahm F; Capper D; Bunt J; Richards LJ; Jones DTW; Korshunov A; Chavez L; Lichter P; Hoshino M; Pfister SM; Kool M; Li W; Kawauchi D
Nat Commun; 2019 Sep; 10(1):3914. PubMed ID: 31477715
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of mitochondrial NAD
Son MJ; Ryu JS; Kim JY; Kwon Y; Chung KS; Mun SJ; Cho YS
Exp Mol Med; 2017 Jun; 49(6):e344. PubMed ID: 28604662
[TBL] [Abstract][Full Text] [Related]
8. Ribogenesis boosts controlled by HEATR1-MYC interplay promote transition into brain tumour growth.
Diaz LR; Gil-Ranedo J; Jaworek KJ; Nsek N; Marques JP; Costa E; Hilton DA; Bieluczyk H; Warrington O; Hanemann CO; Futschik ME; Bossing T; Barros CS
EMBO Rep; 2024 Jan; 25(1):168-197. PubMed ID: 38225354
[TBL] [Abstract][Full Text] [Related]
9. Increased OXPHOS activity precedes rise in glycolytic rate in H-RasV12/E1A transformed fibroblasts that develop a Warburg phenotype.
de Groof AJ; te Lindert MM; van Dommelen MM; Wu M; Willemse M; Smift AL; Winer M; Oerlemans F; Pluk H; Fransen JA; Wieringa B
Mol Cancer; 2009 Jul; 8():54. PubMed ID: 19646236
[TBL] [Abstract][Full Text] [Related]
10. Positive regulation of oxidative phosphorylation by nuclear myosin 1 protects cells from metabolic reprogramming and tumorigenesis in mice.
Venit T; Sapkota O; Abdrabou WS; Loganathan P; Pasricha R; Mahmood SR; El Said NH; Sherif S; Thomas S; Abdelrazig S; Amin S; Bedognetti D; Idaghdour Y; Magzoub M; Percipalle P
Nat Commun; 2023 Oct; 14(1):6328. PubMed ID: 37816864
[TBL] [Abstract][Full Text] [Related]
11. The asymmetrically segregating lncRNA cherub is required for transforming stem cells into malignant cells.
Landskron L; Steinmann V; Bonnay F; Burkard TR; Steinmann J; Reichardt I; Harzer H; Laurenson AS; Reichert H; Knoblich JA
Elife; 2018 Mar; 7():. PubMed ID: 29580384
[TBL] [Abstract][Full Text] [Related]
12. Dynamics of activating and repressive histone modifications in
Abdusselamoglu MD; Landskron L; Bowman SK; Eroglu E; Burkard T; Kingston RE; Knoblich JA
Development; 2019 Dec; 146(23):. PubMed ID: 31748204
[TBL] [Abstract][Full Text] [Related]
13. PI3K activation in neural stem cells drives tumorigenesis which can be ameliorated by targeting the cAMP response element binding protein.
Daniel PM; Filiz G; Brown DV; Christie M; Waring PM; Zhang Y; Haynes JM; Pouton C; Flanagan D; Vincan E; Johns TG; Montgomery K; Phillips WA; Mantamadiotis T
Neuro Oncol; 2018 Sep; 20(10):1344-1355. PubMed ID: 29718345
[TBL] [Abstract][Full Text] [Related]
14. Unraveling the mystery of cancer metabolism in the genesis of tumor-initiating cells and development of cancer.
Zhang G; Yang P; Guo P; Miele L; Sarkar FH; Wang Z; Zhou Q
Biochim Biophys Acta; 2013 Aug; 1836(1):49-59. PubMed ID: 23523716
[TBL] [Abstract][Full Text] [Related]
15. Stem cells in brain tumorigenesis and their impact on therapy.
Cardona AF; Balañá C; Torres D; Becerra H; Ortíz LD; Fadul CE
Curr Stem Cell Res Ther; 2011 Dec; 6(4):339-49. PubMed ID: 21466481
[TBL] [Abstract][Full Text] [Related]
16. Generation of cancerous neural stem cells forming glial tumor by oncogenic stimulation.
Lee JS; Lee HJ; Moon BH; Song SH; Lee MO; Shim SH; Kim HS; Lee MC; Kwon JT; Fornace AJ; Kim SU; Cha HJ
Stem Cell Rev Rep; 2012 Jun; 8(2):532-45. PubMed ID: 21755312
[TBL] [Abstract][Full Text] [Related]
17. Dissecting Hes-centred transcriptional networks in neural stem cell maintenance and tumorigenesis in
Magadi SS; Voutyraki C; Anagnostopoulos G; Zacharioudaki E; Poutakidou IK; Efraimoglou C; Stapountzi M; Theodorou V; Nikolaou C; Koumbanakis KA; Fullard JF; Delidakis C
Development; 2020 Nov; 147(22):. PubMed ID: 33229432
[TBL] [Abstract][Full Text] [Related]
18. A Shifty Target: Tumor-Initiating Cells and Their Metabolism.
Bezuidenhout N; Shoshan M
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31661927
[TBL] [Abstract][Full Text] [Related]
19. An intrinsic mechanism controls reactivation of neural stem cells by spindle matrix proteins.
Li S; Koe CT; Tay ST; Tan ALK; Zhang S; Zhang Y; Tan P; Sung WK; Wang H
Nat Commun; 2017 Jul; 8(1):122. PubMed ID: 28744001
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial pyruvate carrier function determines cell stemness and metabolic reprogramming in cancer cells.
Li X; Han G; Li X; Kan Q; Fan Z; Li Y; Ji Y; Zhao J; Zhang M; Grigalavicius M; Berge V; Goscinski MA; Nesland JM; Suo Z
Oncotarget; 2017 Jul; 8(28):46363-46380. PubMed ID: 28624784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
